chromophobe carcinoma

GPTKB entity

Statements (60)
Predicate Object
gptkbp:instance_of gptkb:healthcare_organization
gptkbp:bfsLayer 6
gptkbp:bfsParent gptkb:Renal_cell_carcinoma
gptkbp:can_metastasize_to liver
lungs
bones
gptkbp:characteristics clear cytoplasm
low nuclear grade
prominent cell borders
gptkbp:displacement gptkb:clear_cell_carcinoma
gptkb:papillary_carcinoma
gptkbp:has_style gptkb:healthcare_organization
https://www.w3.org/2000/01/rdf-schema#label chromophobe carcinoma
gptkbp:is_associated_with hypertension
metabolic syndrome
obesity
chromosomal abnormalities
better prognosis than other renal cancers
gain of 7 and 17 chromosomes
loss of 1 and 2 chromosomes
gptkbp:is_characterized_by abundant eosinophilic cytoplasm
distinct cell borders
perinuclear halo
gptkbp:is_considered differential diagnosis
gptkbp:is_described_as gptkb:academic_journal
gptkbp:is_discussed_in oncology conferences
gptkbp:is_effective_against other renal cancers
gptkbp:is_evaluated_by clinical trials
clinical assessment
gptkbp:is_linked_to environmental factors
genetic predisposition
gptkbp:is_monitored_by blood tests
imaging studies
gptkbp:is_often_used_in gptkb:clear_cell_carcinoma
gptkb:papillary_carcinoma
adults
females
older adults
gptkbp:is_part_of kidney tumors
renal cancer classification.
renal neoplasms
gptkbp:is_recognized_by immunohistochemistry
molecular profiling
gptkbp:is_related_to oncocytoma
gptkbp:is_studied_in clinical trials
gptkbp:is_subject_to research studies
gptkbp:is_used_for weight loss
abdominal pain
hematuria
gptkbp:occurs_in kidneys
gptkbp:reports_to case studies
gptkbp:scientific_classification WHO grade 1
WHO grade 2
gptkbp:social_responsibility histopathological examination
variable outcomes
gptkbp:treatment gptkb:hospital
gptkb:vaccine
radiation therapy
chemotherapy
targeted therapy